PSYCH INVESTOR SUMMIT: RESEARCH & DEVELOPMENT
Join us on 7 July, 2021 for another global psychedelics industry event. Through our concise half-day programme, we will be showcasing the latest research and development in this exciting sector, alongside expanding businesses looking for capital – delivering the industry’s most promising opportunities directly to investors & funds.
Every PSYCH Investor Summit is an opportunity to engage with distinguished industry leaders, rising entrepreneurs and global psychedelics investors to share insights and help develop this emerging frontier.
Rick Doblin (Founder and Executive Director, MAPS)
Christian Angermayer (Founder, atai Life Sciences)
Dr. Ben Sessa (Chief Medical Officer, Awakn Life Sciences)
Plus many more TBA
For Sponsorship & Media enquires contact our team.